Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

TXT — Textron

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 8.01%
Profit Margins 6.15%
Return on Equity 12.25%
Return on Assets 4.56%
Free Float 0.17B
Dividend Yield 9.0%
Short Int % Utilisation 3.15%

2.2 Growth

Metric Value
Revenue Growth 11.8%
Free Cash Flow 0.62B
EBITDA 11.04 (Ratio)
Enterprise Value 18.59B
EV/Revenue 1.22
EV/EBITDA 11.04

Revenue growth of 11.8% indicates steady, moderate expansion.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 17.11%
Risk / Std Dev (Ann.)* 26.61%
1-Year Price Return* 12.92%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $89.00
52-Week Range $78.12 – $101.57
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $14.80B $13.70B
Net income Reported net income $921.00M $824.00M
Total assets Year-end reported balance $18.13B $16.84B
Shareholders’ equity Year-end reported balance $7.88B $7.20B
Net margin Net income ÷ revenue 6.22% 6.01%
Asset turnover Revenue ÷ total assets 0.8163x 0.8138x
Equity multiplier Total assets ÷ shareholders’ equity 2.3021x 2.3373x
ROE Net margin × asset turnover × equity multiplier 11.70% 11.44%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $14.80B
Prior annual revenue $13.70B
EBIT $1.26B
Tax rate 18.80%
NOPAT = EBIT × (1 − tax rate) $1.03B
Forecast start-growth basis 8.01%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $1.03B
Add: depreciation & amortisation $401.00M
Less: capital expenditure -$383.00M
Less/(add): working-capital cash-flow movement -$298.00M
Current unlevered FCFF $745.56M

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 8.01% $1.11B $433.10M -$413.66M -$321.86M $805.25M $773.84M
2 6.63% $1.18B $461.82M -$446.27M -$343.20M $853.45M $757.42M
3 5.25% $1.24B $486.08M -$475.17M -$361.22M $892.83M $731.75M
4 3.88% $1.29B $504.92M -$499.25M -$375.23M $921.77M $697.69M
5 2.50% $1.32B $517.54M -$517.54M -$384.61M $939.01M $656.37M

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 0.91
Cost of equity 9.71%
Pre-tax cost of debt 3.38%
WACC 8.28%
WACC validation within standard range

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $16.64B
Implied terminal EV / EBITDA 7.75x
Terminal value as % of enterprise value 75.56%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $3.62B
Present value of terminal value $11.18B
Indicated enterprise value $14.80B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $14.80B
Less: gross interest-bearing debt $3.88B
Add: cash and equivalents $2.02B
Add: affiliate investments $0.00
Less: minority interests $0.00
Indicated common equity value $12.94B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 180,258,000.00
Share-count basis reported diluted weighted-average shares
Current market price $87.82
DCF indicative value per share $71.81
Indicative value vs. market price -18.24%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range pass
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% within review band

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 4/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:52:10.983869 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha -10.99% -0.20%
Adjusted R² 0.28 0.34
Annualised residual volatility 21.87% 20.79%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 0.81 (6.31) 1.08 (7.67)
Size (SMB) 0.63 (3.62) 0.48 (2.66)
Value (HML) 0.54 (3.64) 0.08 (0.43)
Profitability (RMW) NM 0.25 (1.66)
Investment (CMA) NM 1.03 (3.97)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequitytxtindustrialsaerospace--defensenasdaq